Bing Chuen Chen
Director of Finance/CFO at GLOBAL CORD BLOOD CORPORATION
Profile
Bing Chuen Chen is currently the Chief Financial Officer & Director at Global Cord Blood Corp.
since 2011.
He is also a Director at China Stem Cells Holdings Ltd.
In the past, Mr. Chen served as a Non-Independent Non-Executive Director at Cordlife Group Ltd.
from 2016 to 2019.
He was also the Chief Financial Officer at Golden Meditech Holdings Ltd.Mr. Chen completed his undergraduate degree at Queen's University in 1999.
Bing Chuen Chen active positions
Companies | Position | Start |
---|---|---|
GLOBAL CORD BLOOD CORPORATION | Director of Finance/CFO | 2008-12-31 |
China Stem Cells Holdings Ltd.
China Stem Cells Holdings Ltd. Medical/Nursing ServicesHealth Services China Stem Cells Holdings Ltd. owns and operates cord blood banks. The firm provides stem cell storage facilities and accessory services. Its services include providing cord blood hematopoietic stem cells, answering enquiries about cord blood matching, collecting & storing cord blood as well as peripheral blood stem cells, and research & development of cellular therapies. The company was founded in 1996 and is headquartered Beijing, China. | Director/Board Member | - |
Former positions of Bing Chuen Chen
Companies | Position | End |
---|---|---|
CORDLIFE GROUP LIMITED | Director/Board Member | 2019-06-04 |
GOLDEN MEDITECH HOLDINGS LTD (TDR) | Director of Finance/CFO | - |
Training of Bing Chuen Chen
Queen's University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
GLOBAL CORD BLOOD CORPORATION | Health Services |
CORDLIFE GROUP LIMITED | Health Services |
Private companies | 2 |
---|---|
Golden Meditech Holdings Ltd.
Golden Meditech Holdings Ltd. Medical/Nursing ServicesHealth Services Golden Meditech Holdings Ltd. is an investment company, which engages in the manufacturing and selling of medical devices and related accessories. The company operates its business through the following segments: Healthcare Services, Medical Devices, and Strategic Investments. The Healthcare Services segment is the operation of hospitals, provision of information technology solutions to medical insurance companies and healthcare institutions. The Medical Devices segment is the development, manufacture, sales, and distribution of blood-related medical devices in Mainland China including roducts that are specialized in blood recovery, purification and treatment. The company was founded on September 3, 2001 and is headquartered in Beijing, China. | Health Services |
China Stem Cells Holdings Ltd.
China Stem Cells Holdings Ltd. Medical/Nursing ServicesHealth Services China Stem Cells Holdings Ltd. owns and operates cord blood banks. The firm provides stem cell storage facilities and accessory services. Its services include providing cord blood hematopoietic stem cells, answering enquiries about cord blood matching, collecting & storing cord blood as well as peripheral blood stem cells, and research & development of cellular therapies. The company was founded in 1996 and is headquartered Beijing, China. | Health Services |
- Stock Market
- Insiders
- Bing Chuen Chen